English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/36943
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Title

Atherosclerosis development in apolipoprotein E-null mice deficient for CD69

AuthorsGómez, Manuel; Sanz-González, Silvia M. ; Naim Abu Nabah, Yafa ; Lamana, Amalia; Sánchez Madrid, Francisco; Andrés, Vicente
KeywordsCD69
Atherosclerosis
Apolipoprotein E-null mouse
Issue DateJan-2009
PublisherOxford University Press
CitationCardiovascular Research 81(1): 197-205 (2009)
Abstract[Aims]: Atherosclerosis is a chronic inflammatory disease regulated by immune mechanisms. CD69 is a cell surface receptor rapidly induced after leukocyte activation at sites of chronic inflammation. Genetic disruption of CD69 in the mouse aggravates collagen-induced arthritis (CIA), and partial depletion of CD69-expressing cells with anti-CD69 monoclonal antibody (mAb) prevents CIA development in wild-type mice, suggesting that this receptor negatively modulates immune and inflammatory responses. It has been recently reported that CD69 is upregulated in a large subset of T cells in atherosclerosis-prone apolipoprotein E-null mice (apoE−/−). In this study, we investigated whether altering CD69 function affects atherosclerosis development. [Methods and results]: We studied native and diet-induced atherosclerosis in apoE−/− and doubly deficient apoE−/−CD69−/− mice and performed expression studies in tissues and primary cells derived from these animals. Plasma cholesterol level was unaffected by CD69 genetic inactivation. Although this genetic manipulation led to an elevated production of interferon γ and interleukin 10 by activated T cells, apoE−/− and apoE−/−CD69−/− mice fed control and high-fat diet exhibited atheromas of similar size and composition when analysed at different stages of the disease. Likewise, anti-CD69 mAb treatment had no effect on plasma cholesterol and atherosclerosis burden in fat-fed apoE−/− mice. [Conclusion]: In contrast to previous studies highlighting the protective function of CD69 against CIA, an autoimmune inflammatory disease, our results rule out a significant role for CD69 against atherosclerosis in apoE−/− mice, an experimental disease model featuring a local inflammatory response triggered and sustained by alterations in lipid homeostasis.
Description9 páginas, 6 figuras.-- El documento en word es la versión post-print.
Publisher version (URL)http://dx.doi.org/10.1093/cvr/cvn227
URIhttp://hdl.handle.net/10261/36943
DOI10.1093/cvr/cvn227
ISSN0008-6363
Appears in Collections:(IBV) Artículos
Files in This Item:
File Description SizeFormat 
Cardiovasc. Res. 81197-205 (2009).doc241 kBMicrosoft WordView/Open
Show full item record
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.